Ken Kim, MD, is a renowned expert in healthcare, clinical research, and allergy treatment, with a career spanning over two decades. Kim has been involved in over 800 clinical trials, specializing in allergy, internal medicine, respiratory, and COVID-related treatments, among others.

Kim's professional background includes founding and serving as the principal of Ark Clinical Research, a leading research site specializing in allergy, respiratory, dermatology, and other fields. Additionally, he founded Cosmos Health Solutions, which provides COVID-19 collection and point-of-care testing services to employers and government agencies. Kim also founded WCCT Global, LLC, a full-service CRO focused on early clinical development and oncology and respiratory studies that he served as CEO until 2016.

Kim is board-certified in Internal Medicine and Allergy and Immunology, and his education includes a degree in AB, Biochemical Sciences from Harvard University, and an MD from Harvard Medical School. He has also completed a Health Policy and Management Fellowship at Massachusetts Institute of Technology and an Allergy and Immunology Fellowship at David Geffen School of Medicine at UCLA, where he also completed an internal medicine residency program.

Additionally, Kim is the founder of the Allergy, Asthma, Respiratory Care Medical Center, a specialty allergy/asthma practice in Southern California with expertise in latex allergy and sublingual immunotherapy. He is also an expert witness in over 300 latex allergy, mold claims, medical malpractice, asthma, and anaphylactic reaction cases.